Article
DNA template heterogeneity and <i>in vitro</i> transcription reaction conditions impact the poly(A) tail length and heterogeneity of mRNA
2026-07-03
Abstract excerpt
<h4>ABSTRACT</h4> mRNA technology has emerged as a powerful new class of medicines. Importantly, this RNA-based approach holds promise for treatments beyond vaccines and infectious diseases, including treatments for cancer, metabolic disorders, cardiovascular conditions and autoimmune diseases. The 3’-polyadenylated (poly(A)) tail of mRNA is required for ribosome initiation, translation, and mRNA stability and is...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7734f453-4a6f-583b-bc11-9f2d5eb31fea
- DOI
- 10.64898/2026.07.02.735822
